COLUMBIA, Md.--(BUSINESS WIRE)--Aug. 31, 2006--CELSION CORPORATION (AMEX:CLN) today announced that a study treating tumors in mice with either ThermoDox combined with pulsed high intensity focused ultrasound (HIFU) or Doxil(R) combined with pulsed HIFU will be presented at the 6th International Symposium on Therapeutic Ultrasound in Oxford, England (30th August - 2nd September 2006).
